U.S., Oct. 8 -- An application to own the trademark for 'SOLITAIRE SOCIAL' has been filed on Dec. 29, 2022. Owner(s): Kosmos Games (Cyprus) Ltd.; 28 Oktovriou str. 367, Office A5, 1st floor,, Medite... Read More
U.S., Oct. 8 -- An application to own the trademark for 'INVIREO' has been filed on Mar. 14, 2023. Owner(s): INEOS Europe AG; Avenue des Uttins 3, CH-1180 Rolle, SWITZERLAND Goods and/or Services: ... Read More
U.S., Oct. 8 -- An application to own the trademark for 'SHERPA' has been filed on Apr. 19, 2023. Owner(s): KAWASAKI JUKOGYO KABUSHIKI KAISHA; 1-1, Higashikawasaki-cho 3-chome,, Chuo-ku Kobe, JAPAN ... Read More
U.S., Oct. 8 -- An application to own the trademark for 'BLUENZYME' has been filed on Mar. 30, 2023. Owner(s): SAIPEM S.P.A.; VIA LUIGI RUSSOLO 5, I-20138 MILANO, ITALY Goods and/or Services: For:... Read More
U.S., Oct. 8 -- An application to own the trademark for 'VOQUZ' has been filed on May. 16, 2023. Owner(s): VOQUZ TECHNOLOGIES GmbH; Rennweg 97-99, A-1030 Wien, AUSTRIA Goods and/or Services: For: ... Read More
U.S., Oct. 8 -- An application to own the trademark for 'VOQUZ' has been filed on May. 16, 2023. Owner(s): VOQUZ TECHNOLOGIES GmbH; Rennweg 97-99, A-1030 Wien, AUSTRIA Goods and/or Services: For: ... Read More
U.S., Oct. 8 -- An application to own the trademark for 'ESCENT PARFUMURI' has been filed on Apr. 26, 2023. Owner(s): SC DUBAI SCENT SRL; Str. Plt. Radu Gheorghe nr. 5, bl. 12,, sc. A, Et. 5, Ap. 21... Read More
U.S., Oct. 8 -- An application to own the trademark for 'MUSHEE GET ZAPPED' has been filed on Mar. 17, 2023. Owner(s): BAR1 BRANDS LIMITED; Chandler House,, 7 Ferry Road Office Park Preston PR2 2YH,... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1060250059) titled 'Wound closure for the prevention of complications after endoscopic tre... Read More
Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2011250040) titled 'A Multicentre, Parallel-group, Phase IIb, Randomised, Double-blind, Pl... Read More